title: Borderline personality disorder and polycystic ovary syndrome.
authors.affiliation: The Monash Alfred Psychiatry Research Centre (MAPrc), Melbourne, VIC, Australia.
authors.forename: Roth
authors.initials: R
authors.lastname: Trisno
authors.affiliation: The Monash Alfred Psychiatry Research Centre (MAPrc), Melbourne, VIC, Australia.
authors.forename: Roisin
authors.initials: R
authors.lastname: Worsley
authors.affiliation: The Monash Alfred Psychiatry Research Centre (MAPrc), Melbourne, VIC, Australia j.kulkarni@alfred.org.au.
authors.forename: Jayashri
authors.initials: J
authors.lastname: Kulkarni
mesh_terms: D001883:Borderline Personality Disorder / Q000150:complications*; D004958:Estradiol / Q000627:therapeutic use*; D004967:Estrogens / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008687:Metformin / Q000627:therapeutic use*; D011085:Polycystic Ovary Syndrome / Q000150:complications / Q000188:drug therapy*; D011374:Progesterone / Q000627:therapeutic use*; D011372:Progestins / Q000627:therapeutic use*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D004967:Estrogens; D007004:Hypoglycemic Agents; D011372:Progestins; D011374:Progesterone; D004958:Estradiol; D008687:Metformin